No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 58 (3) , 981-988
- https://doi.org/10.1046/j.1523-1755.2000.00255.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRDKidney International, 1994
- CLINICAL REVIEW 20 Recent Advances in the Pathogenesis and Therapy of Uremic Secondary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1991
- Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?The Lancet, 1991
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremiaKidney International, 1989
- Parathyroid hormone and 1,25(OH)2D3 in chronic renal failureKidney International, 1988
- Bone disease in pediatric patients undergoing dialysis with CAPD or CCPDKidney International, 1988
- SUPPRESSION BY 1,25(OH)2D3OF TRANSCRIPTION OF THE PRE–PR0PARATHYR0ID HORMONE GENEEndocrinology, 1986
- Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.Journal of Clinical Investigation, 1986
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984